Swiss and Belgian Companies Collaborate on Peptide-Based Cold Vaccines
AlgoNomics and Pevion Biotech said this week that they will collaborate to develop peptides for cold vaccines.
Over a period of a year and a half, structural bioinformatics company AlgoNomics, based in Ghent, Belgium, will use its Tripole protein modeling and peptide design technologies to develop peptides derived from Respiratory Syncytial Virus, which causes the common cold and other respiratory illnesses.
MDS Sciex Taps Unichom for Taiwanese NanoLC Distribution
MDS Sciex announced this week that it has chosen Unichom, a Taiwanese separations technologies distribution company, to distribute its NanoLC system in Taiwan. Unichrom is showcasing the technology at the 9th Taipei International Instruments Show being held this week at the Taipei World Trade Center in Taipei, Taiwan.
MDL to Distribute Inpharmatica’s Proteome Database
MDL Information Systems and Inpharmatica said this week that MDL would serve as a non-exclusive distributor for Inpharmatica’s Biopendium proteome annotation database.
Under the agreement, MDL, a wholly owned subsidiary of scientific publisher Elsevier, will offer both installed and hosted versions of Biopendium worldwide, with the exception of Japan. Other terms of the agreement were not disclosed.
Indian Text-mining Company to Analyze Data for MDS Proteomics
Molecular Connections, a biomedical text-mining firm based in Bangalore, India, said this week that it has penned a deal with MDS Proteomics of Toronto to analyze MDSP’s data.
Under the terms of the agreement, Molecular Connections will apply its literature-curation and -annotation services to experimental data provided by MDSP. According to Molecular Connections, its analysis methods will provide additional information on protein function, protein interactions, protein expression, and disease association.
Cengent and U of Alabama Collaborate on High-Throughput Structure Determination
Cengent Therapeutics announced this week that it will collaborate with the Center for Biophysical Sciences and Engineering at the University of Alabama, Birmingham to provide a joint target/drug-lead structure determination service.
Cengent’s computational Gene to Leads technology will now be used with CBSE’s established high-throughput X-ray crystallography service for industry.
Â